The CHIPTS mission aims to leverage world class science to combat HIV globally, in partnership with communities impacted by the pandemic. We prioritize our research efforts on HIV identification, prevention, and treatment services. To achieve our mission, we collaborate with world-renowned investigators from UCLA, Charles R. Drew University of Medicine and Science (Drew), RAND Corporation (RAND), Friends Research Institute (Friends) and other research and community partners in the U.S. and abroad. The complex challenges of a different world demand a refining of the focus of CHIPTS. To respond to these emerging scientific issues, we will: 1) broaden our agenda to include a domestic and an international research agenda;2) systematically study pioneering intervention strategies, especially those that integrate emerging biomedical technologies, novel delivery vehicles and direct consumer involvement to adapt and adopt effective programs;and 3) determine the benefits and costs of policies aimed at reducing HIV at individual, family, community, national, and international levels. CHIPTS agenda will be implemented through six cores: Administrative, Development, Methods, Policy, Intervention and International. Two of our previous six Cores will change. We will establish an International Core, in this competing continuation application, to provide a mechanism whereby CHIPTS scientists can link our domestic and international projects for their mutual benefit. The expertise of the former Treatment Services Core will become part of the Intervention Core. Over the next five years, the CHIPTS Intervention Core will increase the reach of behavioral interventions for high-risk groups and build upon existing behavioral and biomedical collaborator efforts to develop and evaluate new biomedical approaches to prevention. The mission of CHIPTS is advanced through specific science, networking and capacity building goals and key scientific themes. As a Center, CHIPTS hopes to leverage human capital and financial support to make a significant impact by bringing insights from behavioral science to the implementation of biomedical technologies for HIV prevention, to adapt and adopt efficacious interventions and to apply digital technology to HIV prevention efforts. CHIPTS is both a source and summit of resources for our local and international partners and makes a critical and sustainable impact in HIV identification, prevention and treatment studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH058107-15
Application #
8020903
Study Section
Special Emphasis Panel (ZMH1-ERB-N (11))
Program Officer
Gordon, Christopher M
Project Start
1997-09-30
Project End
2012-01-31
Budget Start
2011-03-15
Budget End
2012-01-31
Support Year
15
Fiscal Year
2011
Total Cost
$2,113,393
Indirect Cost
Name
University of California Los Angeles
Department
Type
Other Domestic Higher Education
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Shin, S S; Chang, A H; Ghosh, J K C et al. (2016) Isoniazid therapy for Mycobacterium tuberculosis infection in HIV clinics, Los Angeles, California. Int J Tuberc Lung Dis 20:961-6
Wynn, Adriane; Ramogola-Masire, Doreen; Gaolebale, Ponatshego et al. (2016) Acceptability and Feasibility of Sexually Transmitted Infection Testing and Treatment among Pregnant Women in Gaborone, Botswana, 2015. Biomed Res Int 2016:1251238
Perez-Brumer, Amaya G; Oldenburg, Catherine E; Segura, Eddy R et al. (2016) Anonymous partnerships among MSM and transgender women (TW) recently diagnosed with HIV and other STIs in Lima, Peru: an individual-level and dyad-level analysis. Sex Transm Infect :
Roberts, Chelsea P; Klausner, Jeffrey D (2016) Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men. Expert Rev Anti Infect Ther 14:1037-1046
Okafor, Chukwuemeka N; Cook, Robert L; Chen, Xinguang et al. (2016) Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984-2013. AIDS Behav :
Tomlinson, Mark; Rotheram-Borus, Mary Jane; le Roux, Ingrid M et al. (2016) Thirty-Six-Month Outcomes of a Generalist Paraprofessional Perinatal Home Visiting Intervention in South Africa on Maternal Health and Child Health and Development. Prev Sci 17:937-948
Pines, Heather A; Gorbach, Pamina M; Weiss, Robert E et al. (2016) Individual-Level, Partnership-Level, and Sexual Event-Level Predictors of Condom Use During Receptive Anal Intercourse Among HIV-Negative Men Who Have Sex with Men in Los Angeles. AIDS Behav 20:1315-26
Herbst de Cortina, Sasha; Bristow, Claire C; Joseph Davey, Dvora et al. (2016) A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Infect Dis Obstet Gynecol 2016:4386127
Tsai, Alexander C; Tomlinson, Mark; Comulada, W Scott et al. (2016) Intimate Partner Violence and Depression Symptom Severity among South African Women during Pregnancy and Postpartum: Population-Based Prospective Cohort Study. PLoS Med 13:e1001943
Diaz, Chanelle M; Segura, Eddy R; Luz, Paula M et al. (2016) Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infect Dis 16:376

Showing the most recent 10 out of 489 publications